Injective (INJ) is trading at $8.27, a 1% increase from the previous day. Market data shows a trading volume of $83.01 million, up by 18.55%, suggesting renewed investor interest in the decentralized finance (DeFi) protocol. Over the past week, INJ has maintained a relatively steady trajectory, averaging $8.48, representing a 0.84% rise.
Despite minor gains, Injective remains in a consolidation phase. Market sentiment appears cautious, as traders continue to assess the potential for a decisive move. The current trading range reflects broader uncertainty in the cryptocurrency market, with investors awaiting a stronger directional signal.
Crypto analyst Lennaert Snyder noted that Injective is “trading within a range,” emphasizing the need for a breakout to establish a definitive trend. Snyder outlined two critical levels to watch: a break above $10.00 could trigger bullish momentum and attract long positions, while a drop below $7.80 could lead to short positions and renewed selling pressure.
Until either threshold is breached, traders are expected to employ range-based strategies, alternating between buying near support and selling near resistance. Snyder’s technical assessment mirrors a growing consensus among market participants who anticipate significant volatility once the current stagnation resolves.
Also Read | Injective (INJ) Faces Bearish Breakdown as Analyst Targets $9
https://digitalcoinprice.com/forecast/injectiveAccording to DigitalCoinPrice, INJ could approach $18.64 by late 2025, possibly surpassing its previous all-time high of $52.75 in subsequent cycles. The analysis anticipates the token stabilizing between $18.01 and $18.64, backed by long-term investor confidence and expanding DeFi adoption.
Meanwhile, Changelly’s 2025 outlook projects a slightly conservative range, with prices averaging $14.47, peaking at $15.27, and a minimum near $13.95. The platform estimates a potential return on investment (ROI) of up to 80.9%, suggesting strong recovery prospects from current levels.
As of October 2025, analysts expect Injective to trade between $8.29 and $14.97, aligning with a 77.4% potential ROI. Overall, the consensus indicates that while short-term movements may remain range-bound, the long-term trajectory for Injective points toward steady and sustainable growth.
Also Read | Injective (INJ) Price Prediction 2025: Analysts Eye Explosive Surge Toward $50
